Histone demethylases regulate ferroptosis in metabolic dysfunction‐associated steatotic liver disease via epigenetic modification
The FEBS Journal · 2026
DOI: 10.1111/febs.70351 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FEBS Journal, 2026. Verfasst von Wentao Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Basic Medical Sciences, Hunan Normal University, Changsha, China. Hauptthemen laut MEDLINE: Ferroptosis, Epigenesis, Genetic, Histone Demethylases, Fatty Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 200 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hubei University of Science and Technology Development Fund Project, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Ferroptosis, an iron‐dependent, non‐apoptotic form of cell death, is characterised by pathogenic lipid reactive oxygen species accumulation, dysregulated iron homeostasis, and oxidative stress‐induced membrane damage. Numerous studies have demonstrated that ferroptosis plays a critical role in the pathogenesis of metabolic disorders and related cancers, particularly metabolic dysfunction‐associated steatotic liver disease (MASLD) and hepatocellular carcinoma. Epigenetic modifications, notably aberrant expression of histone lysine demethylases (KDMs), have been strongly associated with both ferroptosis and MASLD. This review systematically summarises how KDM family members regulate ferroptosis‐related gene transcription through epigenetic mechanisms, along with their specific roles in MASLD progression. Additionally, current progress and challenges in the potential application of KDM inhibitors in regulating ferroptosis and MASLD treatment are discussed, with the aim of providing a scientific foundation for the translational development of therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, School of Basic Medical Sciences, Hunan Normal University, Changsha, China.
- School of Basic Medical Sciences, Hubei University of Science and Technology, Xianning, China.
- Hubei Key Laboratory of Diabetes and Angiopathy, School of Pharmacy, Hubei University of Science and Technology, Xianning, China.
- Department of Scientific Research and Education, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
- The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medic…
Förderung
- National Natural Science Foundation of China
- Hubei University of Science and Technology Development Fund Project
- Natural Science Foundation of Hubei Province
Zitieren
APA
Huang, W., Wu, W., Xiao, J., Bai, Y., Chen, C., Ou, H., Ma, Y., Que, X., Shan, S., Qu, L., & Shen, L. (2026). Histone demethylases regulate ferroptosis in metabolic dysfunction‐associated steatotic liver disease via epigenetic modification. The FEBS Journal. https://doi.org/10.1111/febs.70351
Vancouver
Huang W, Wu W, Xiao J, Bai Y, Chen C, Ou H, et al. Histone demethylases regulate ferroptosis in metabolic dysfunction‐associated steatotic liver disease via epigenetic modification. The FEBS Journal. 2026. doi:10.1111/febs.70351
BibTeX
@article{Huang2026,
author = {Huang, Wentao and Wu, Wanqiu and Xiao, Jiaqi and Bai, Yujie and Chen, Chao and Ou, Haoxiang and Ma, Yaoyao and Que, Xinyu and Shan, Shigang and Qu, Lihua and Shen, Li},
title = {Histone demethylases regulate ferroptosis in metabolic dysfunction‐associated steatotic liver disease via epigenetic modification},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70351}
}
EUVIMED